JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB126538

Anti-LOX 1 antibody

Be the first to review this product! Submit a review

|

(10 Publications)

Rabbit Polyclonal LOX 1 antibody. Suitable for WB, ICC/IF, IHC-P and reacts with Human samples. Cited in 10 publications.

View Alternative Names

CLEC8A, LOX1, OLR1, Oxidized low-density lipoprotein receptor 1, Ox-LDL receptor 1, C-type lectin domain family 8 member A, Lectin-like oxidized LDL receptor 1, Lectin-type oxidized LDL receptor 1, LOX-1, Lectin-like oxLDL receptor 1, hLOX-1

4 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LOX 1 antibody (AB126538)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LOX 1 antibody (AB126538)

IHC image of LOX 1 staining in human kidney formalin fixed paraffin embedded tissue section, performed on a Leica Bond system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab126538, 5μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

Immunocytochemistry/ Immunofluorescence - Anti-LOX 1 antibody (AB126538)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-LOX 1 antibody (AB126538)

ab126538 staining LOX 1 in HeLa cells. The cells were fixed with 4% paraformaldehyde (10 min), permeabilized with 0.1% PBS-Tween for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1%PBS-Tween for 1h. The cells were then incubated overnight at 4°C with ab126538 at 5µg/ml and ab7291, Mouse monoclonal [DM1A] to alpha Tubulin - Loading Control. Cells were then incubated with ab150081, Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (Alexa Fluor® 488), pre-adsorbed at 1/1000 dilution (shown in green) and ab150120, Goat polyclonal Secondary Antibody to Mouse IgG - H&L (Alexa Fluor® 594), pre-adsorbed at 1/1000 dilution (shown in pseudocolour red). Nuclear DNA was labelled with DAPI (shown in blue).

Image was acquired with a high-content analyser (Operetta CLS, Perkin Elmer) and a maximum intensity projection of confocal sections is shown.

Immunocytochemistry/ Immunofluorescence - Anti-LOX 1 antibody (AB126538)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-LOX 1 antibody (AB126538)

ab126538 staining LOX 1 in HepG2 cells. The cells were fixed with 4% paraformaldehyde (10 min), permeabilized with 0.1% PBS-Tween for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1%PBS-Tween for 1h. The cells were then incubated overnight at 4°C with ab126538 at 5µg/ml and ab7291, Mouse monoclonal [DM1A] to alpha Tubulin - Loading Control. Cells were then incubated with ab150081, Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (Alexa Fluor® 488), pre-adsorbed at 1/1000 dilution (shown in green) and ab150120, Goat polyclonal Secondary Antibody to Mouse IgG - H&L (Alexa Fluor® 594), pre-adsorbed at 1/1000 dilution (shown in pseudocolour red). Nuclear DNA was labelled with DAPI (shown in blue).

Image was acquired with a high-content analyser (Operetta CLS, Perkin Elmer) and a maximum intensity projection of confocal sections is shown.

Western blot - Anti-LOX 1 antibody (AB126538)
  • WB

Unknown

Western blot - Anti-LOX 1 antibody (AB126538)

LOX 1 contains a number of potential glycosylation sites (SwissProt) which may explain its migration at a higher molecular weight than predicted (55 kDa). This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 5% Bovine Serum Albumin before being incubated with ab126538 overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP, and visualised using ECL development solution.

All lanes:

Western blot - Anti-LOX 1 antibody (ab126538) at 1 µg/mL

Lane 1:

HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg

Lane 2:

Human placenta tissue lysate - total protein (<a href='/en-us/products/unavailable/human-placenta-tissue-lysate-total-protein-ab29745'>ab29745</a>) at 10 µg

Lane 3:

Lung (Human) Tissue Lysate at 10 µg

Lane 4:

HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/10000 dilution

Predicted band size: 31 kDa

Observed band size: 15 kDa,31 kDa,55 kDa,80 kDa

true

Exposure time: 3min

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ICC/IF, WB, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "5 µg/mL", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "5 µg/mL", "IHCP-species-notes": "<p></p>" }, "Chimpanzee": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Gorilla": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Macaque monkey": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Orangutan": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Receptor that mediates the recognition, internalization and degradation of oxidatively modified low density lipoprotein (oxLDL) by vascular endothelial cells. OxLDL is a marker of atherosclerosis that induces vascular endothelial cell activation and dysfunction, resulting in pro-inflammatory responses, pro-oxidative conditions and apoptosis. Its association with oxLDL induces the activation of NF-kappa-B through an increased production of intracellular reactive oxygen and a variety of pro-atherogenic cellular responses including a reduction of nitric oxide (NO) release, monocyte adhesion and apoptosis. In addition to binding oxLDL, it acts as a receptor for the HSP70 protein involved in antigen cross-presentation to naive T-cells in dendritic cells, thereby participating in cell-mediated antigen cross-presentation. Also involved in inflammatory process, by acting as a leukocyte-adhesion molecule at the vascular interface in endotoxin-induced inflammation. Also acts as a receptor for advanced glycation end (AGE) products, activated platelets, monocytes, apoptotic cells and both Gram-negative and Gram-positive bacteria.. (Microbial infection) May serve as a receptor for adhesin A variant 3 (nadA) of N.meningitidis.
See full target information OLR1

Publications (10)

Recent publications for all applications. Explore the full list and refine your search

Journal for immunotherapy of cancer 13: PubMed40998518

2025

High Treg and PMN-MDSC densities are a hallmark of tertiary lymphoid structures in fatal cases of cervical cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Linn A Syding,Klára Plačková,Lucie Pavelková,Cecilia Aquino-Perez,Saskia J Santegoets,Jan Laco,Marek Grega,Pavel Dundr,Kristýna Němejcová,Miroslav Hodek,Jan Bouček,Michal Zábrodský,Hana Vošmiková,Michael J Halaška,Lukáš Rob,Petr Čelakovský,Viktor Chrobok,Munachiso Ndukwe Iheme,Ivan Práznovec,Milan Vošmik,Stanislav Katina,David Cibula,Aleš Ryška,Sjoerd H van der Burg,Radek Špíšek,Anna Fialová

Scientific reports 15:8774 PubMed40082457

2025

Roles of C-reactive protein and LOX-1 on cancer and myeloid-derived suppressor cells in the progression of uterine cervical cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Michihide Maeda,Seiji Mabuchi,Takashi Akazawa,Yu Mizote,Tomoyuki Sasano,Naoko Komura,Mina Sakata,Tsuyoshi Takiuchi,Shinya Matsuzaki,Tsuyoshi Hisa,Harumi Nakamura,Tomoya Ekawa,Shoji Kamiura,Tadashi Kimura,Hideaki Tahara

Frontiers in neuroscience 18:1442110 PubMed39234183

2024

Lectin-type oxidized LDL receptor-1 as a potential therapeutic target for cerebral cavernous malformations treatment.

Applications

Unspecified application

Species

Unspecified reactive species

Karthik Ashok,Tyra Martinez,Julie Sesen,Sana Nasim,Shih-Shan Lang,Gregory Heuer,Alexander Tucker,Miguel Alejandro Lopez-Ramirez,Edward R Smith,Aram Ghalali

Cancer research 83:3205-3219 PubMed37409887

2023

Galectin-1 Mediates Chronic STING Activation in Tumors to Promote Metastasis through MDSC Recruitment.

Applications

Unspecified application

Species

Unspecified reactive species

Dhanya K Nambiar,Vignesh Viswanathan,Hongbin Cao,Weiruo Zhang,Li Guan,Manish Chamoli,Brittany Holmes,Christina Kong,Rachel Hildebrand,Amanda Jeanette Koong,Rie von Eyben,Sylvia Plevritis,Lingyin Li,Amato Giaccia,Edgar Engleman,Quynh Thu Le

International journal of biological sciences 19:1813-1830 PubMed37063419

2023

Autophagic degradation of LOX-1 is involved in the maintenance of vascular integrity injured by oxLDL and protected by Berberine.

Applications

Unspecified application

Species

Unspecified reactive species

Yangmin Zheng,Bo Chen,Miaoqing Zhang,Yuanyuan Ma,Lulu Wang,Jingpu Zhang,Jiandong Jiang

Cancer reports (Hoboken, N.J.) 4:e1364 PubMed33675293

2021

Low level of stromal lectin-like oxidized LDL receptor 1 and CD8 cytotoxic T-lymphocytes indicate poor prognosis of colorectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Chika Katayama,Takehiko Yokobori,Naoya Ozawa,Kunihiko Suga,Takuya Shiraishi,Takuhisa Okada,Katsuya Osone,Ryuji Katoh,Toshinaga Suto,Yoko Motegi,Hiroomi Ogawa,Akihiko Sano,Makoto Sakai,Makoto Sohda,Bilguun Erkhem-Ochir,Navchaa Gombodorj,Ayaka Katayama,Tetsunari Oyama,Ken Shirabe,Hiroyuki Kuwano,Hiroshi Saeki

Immunology 154:144-155 PubMed29211299

2017

Endoplasmic reticulum stress induced LOX-1 CD15 polymorphonuclear myeloid-derived suppressor cells in hepatocellular carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Jiang Nan,Yan-Fang Xing,Bo Hu,Jian-Xin Tang,Hui-Min Dong,Yu-Mei He,Dan-Yun Ruan,Qing-Jian Ye,Jia-Rong Cai,Xiao-Kun Ma,Jie Chen,Xiu-Rong Cai,Ze-Xiao Lin,Xiang-Yuan Wu,Xing Li

Cancer cell 32:654-668.e5 PubMed29136508

2017

Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors.

Applications

Unspecified application

Species

Unspecified reactive species

Vinit Kumar,Laxminarasimha Donthireddy,Douglas Marvel,Thomas Condamine,Fang Wang,Sergio Lavilla-Alonso,Ayumi Hashimoto,Prashanthi Vonteddu,Reeti Behera,Marlee A Goins,Charles Mulligan,Brian Nam,Neil Hockstein,Fred Denstman,Shanti Shakamuri,David W Speicher,Ashani T Weeraratna,Timothy Chao,Robert H Vonderheide,Lucia R Languino,Peter Ordentlich,Qin Liu,Xiaowei Xu,Albert Lo,Ellen Puré,Chunsheng Zhang,Andrey Loboda,Manuel A Sepulveda,Linda A Snyder,Dmitry I Gabrilovich

Journal of cellular and molecular medicine 21:2823-2836 PubMed28524645

2017

C1q/TNF-related protein 9 inhibits the cholesterol-induced Vascular smooth muscle cell phenotype switch and cell dysfunction by activating AMP-dependent kinase.

Applications

Unspecified application

Species

Human

Qi Liu,Hui Zhang,Jiale Lin,Ruoxi Zhang,Shuyuan Chen,Wei Liu,Meng Sun,Wenjuan Du,Jingbo Hou,Bo Yu

Science immunology 1: PubMed28417112

2016

Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients.

Applications

Unspecified application

Species

Unspecified reactive species

Thomas Condamine,George A Dominguez,Je-In Youn,Andrew V Kossenkov,Sridevi Mony,Kevin Alicea-Torres,Evgenii Tcyganov,Ayumi Hashimoto,Yulia Nefedova,Cindy Lin,Simona Partlova,Alfred Garfall,Dan T Vogl,Xiaowei Xu,Stella C Knight,George Malietzis,Gui Han Lee,Evgeniy Eruslanov,Steven M Albelda,Xianwei Wang,Jawahar L Mehta,Meenakshi Bewtra,Anil Rustgi,Neil Hockstein,Robert Witt,Gregory Masters,Brian Nam,Denis Smirnov,Manuel A Sepulveda,Dmitry I Gabrilovich
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com